New somatostatin molecule for management of endocrine tumours.
Bonfils
S
S
D000818:Animals; D004341:Drug Evaluation / Q000379:methods; D006801:Humans; D015282:Octreotide; D009384:Paraneoplastic Endocrine Syndromes / Q000188:drug therapy*; D013004:Somatostatin / Q000009:adverse effects / Q000031:analogs & derivatives* / Q000627:therapeutic use
D013004:Somatostatin; D015282:Octreotide